Alps Group Inc Reports Fiscal Year 2026 Financial Results
Revenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics…
Alps Group Inc Launches Patient-Derived Organoid Program to
KUALA LUMPUR, Malaysia, June 23, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS),…
Alps Announces Closing of Business Combination with
KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or…
Alps Group Appoints Former Ernst & Young Partner to Board
KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or “Alps Group”), the…
Alps Group Appoints Former Ernst & Young Partner to Board
KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or “Alps Group”), the…
Alps Group Inc Announces Potential Pipeline Expansion
KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or “Alps Group”), the…
Alps Announces Closing of Business Combination with
KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or…
Alps Group Inc Publishes Clinical Safety, Tolerability and
KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or “Alps Group”), the…